Respiratory Virus Metagenomics After COVID-19
ConditionCOVID-19 Respiratory Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
The study aims to characterize the distributive pattern of viruses in upper airway and its relationship with influenza seasons, symptomatology and exposure setting. A total of 500 adults residing in Hong Kong would be recruited, who would complete a questionnaire and return self-collected nasal and throat swabs for metagenomic analyses.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
adults normally residing in Hong Kong
could communicate in English and/or Chinese
provision of consent
Disqualifiers
individuals with mental illness
prisoners
Trial population
Subjects would be invited by post through randomly selected households throughout the territory of Hong Kong.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Positive identification of viruses
Proportion of specimens with identified respiratory virus taxa
Time frame
4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov